Friday, August 10, 2012
After 10 months, PacBio chief commercial officer Michael Glynn resigns
Michael Glynn, who joined Pacific Biosciences of California less than a year ago, is stepping down as chief commercial officer. The Menlo Park company (NASDAQ: PACB) broke the news Friday in a one-sentence filing with the Securities and Exchange Commission. The company did not say what prompted Glynn's resignation or hint at his personal plans.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment